The National Institutes of Health (MD, USA) have begun a Phase I clinical trial examining a vaccine intended to provide broad protection against a range of mosquito-borne diseases by targeting the insect’s saliva.
Researchers have utilized a novel mouse model to demonstrate that Zika infection during early pregnancy could lead to higher risk of miscarriage in addition to thin brain tissue and brain inflammation in infants.
Researchers have demonstrated that nanoparticles, such as those from burning fossil fuels, appear to reactivate latent herpesviruses in lung tissue.
Researchers have demonstrated that a new whole-parasite vaccine could provide up to 100% protection in clinical trials carried out at the University of Tübingen (Germany).
A new meta-analysis has presented findings reporting that regular vitamin D supplementation could drastically lower the risk of acute respiratory infections.
Researchers have suggested that a virion protein known as BNRF1, produced by the Epstein–Barr Virus, may be responsible for tumor formation.
Researchers have suggested that disease “superspreaders” may have been responsible for two-thirds of cases in the West Africa Ebola epidemic. Targeting these individuals could lead to better disease control measures in future outbreaks.
Researchers have created a model to assess the benefits of vaccination on the burden of non-typhoidal salmonella in Mali; the research could inform policy in many countries where there is high risk of these infections.
Researchers have uncovered a mechanism utilized by Zika virus to cross the placental barrier; this has provided an insight into the virus’ ability to cause birth defects such as microcephaly
A recent study has demonstrated that drought is linked with increased severity of West Nile virus epidemics in the USA; these findings could help predict future outbreaks and guide public health efforts.